For sales

📢Highlights from the Week of 07 July , 2025 – 14 July, 2025 in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of July 07-14, 2025 VYUHPHARMA (Alzheimers, FDA) Lilly Lilly's KISUNLA gets FDA nod for safer dosing in early Alzheimer's, reducing ARIA-E risk by 41% (Breakthrough Therapy, FDA) transcend THERAPEUTICS Transcend Therapeutics has been granted Breakthrough Therapy Designation for TSND- 201 (methylone) for the treatment of PTSD (Denosumab Biosimilars) CELLTRION Celltrion launches STOBOCLO and OSENVELT (biosimilars to PROLIA and XGEVA) in the U.S. Myr elle (Gene Therapy, Canavan Disease) Myrtelle launches a commercial-stage manufacturing of MYR-101, its rAAV gene therapy for Canavan disease, in partnership with Charles River and Viralgen Pg 1/4 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.